Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-09-26
2006-09-26
Page, Thurman K. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
65, 65
Reexamination Certificate
active
07112577
ABSTRACT:
A pharmaceutically acceptable alendronate salt in an amorphous form.
REFERENCES:
patent: 4304734 (1981-12-01), Jary et al.
patent: 4922007 (1990-05-01), Kieczykowski et al.
patent: 6268524 (2001-07-01), Shinal
patent: 0402152 (1990-12-01), None
patent: 9639149 (1996-12-01), None
patent: 0012517 (2000-03-01), None
patent: 0034293 (2000-06-01), None
patent: 0130788 (2001-05-01), None
patent: WO 01/30788 (2001-05-01), None
Hamied Yusuf Khwaja
Kankan Rajendra Narayanrao
Rao Dharmaraj Ramachandra
Cipla Limited
Nwaonicha Chukwuma
Page Thurman K.
Stevens Davis Miller & Mosher L.L.P.
LandOfFree
Pharmaceutically acceptable alendronate salts in amorphous form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically acceptable alendronate salts in amorphous form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically acceptable alendronate salts in amorphous form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3540786